🇮🇳 Qulipta in India

Qulipta (ATOGEPANT) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Qulipta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in India

Frequently asked questions

Is Qulipta approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Qulipta in India?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.